Merit Medical Systems, Inc. reported second-quarter 2026 revenue of approximately $418 million and adjusted earnings per share of $1.19 on Thursday [1, 2].
The results indicate a period of significant growth for the medical-device company, prompting an increase in full-year guidance and higher forecasts from market analysts.
Headquartered in South Jordan, Utah, the company posted a net profit of $38.8 million [3]. The reported revenue ranged between $418 million [1] and $418.8 million [2], representing a 10 percent increase on a constant-currency basis compared to the previous year [2].
Financial performance exceeded expectations for the quarter. Adjusted earnings per share reached $1.19 [1], while analysts had estimated a figure of $0.96 [1]. Non-adjusted earnings per share were reported at $0.65 [3].
These figures reflect the company's current trajectory as it expands its market presence. The strong sales growth and earnings beat led the firm to update its outlook for the remainder of the year [2].
Merit Medical released these results via a conference call and on its corporate website [4]. The company's ability to outperform estimates suggests a robust demand for its device portfolio across its operating markets.
“Merit Medical Systems, Inc. reported second-quarter 2026 revenue of approximately $418 million”
The discrepancy between adjusted and non-adjusted earnings per share highlights the impact of one-time costs or accounting adjustments on the company's bottom line. However, the 10 percent year-over-year revenue growth and the decision to raise full-year guidance suggest that Merit Medical is experiencing sustainable operational scaling rather than a temporary spike, which typically strengthens investor confidence in the medical technology sector.
